Sanofi (SNY) Invested Capital (2016 - 2025)
Sanofi (SNY) has disclosed Invested Capital for 11 consecutive years, with $104.9 billion as the latest value for Q4 2025.
- Quarterly Invested Capital rose 4.78% to $104.9 billion in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $104.9 billion through Dec 2025, up 4.78% year-over-year, with the annual reading at $101.8 billion for FY2025, 0.41% changed from the prior year.
- Invested Capital hit $104.9 billion in Q4 2025 for Sanofi, up from $100.1 billion in the prior quarter.
- In the past five years, Invested Capital ranged from a high of $104.9 billion in Q4 2025 to a low of $95.9 billion in Q4 2022.
- Historically, Invested Capital has averaged $100.0 billion across 5 years, with a median of $100.1 billion in 2024.
- Biggest five-year swings in Invested Capital: decreased 5.73% in 2022 and later increased 4.78% in 2025.
- Year by year, Invested Capital stood at $101.7 billion in 2021, then dropped by 5.73% to $95.9 billion in 2022, then increased by 1.61% to $97.4 billion in 2023, then grew by 2.69% to $100.1 billion in 2024, then grew by 4.78% to $104.9 billion in 2025.
- Business Quant data shows Invested Capital for SNY at $104.9 billion in Q4 2025, $100.1 billion in Q4 2024, and $97.4 billion in Q4 2023.